Mr. Pierre Laurin reports
PROMETIC ANNOUNCES THE EXERCISE OF THE OVER-ALLOTMENT OPTION UNDER ITS BOUGHT DEAL OFFERING OF COMMON SHARES
ProMetic Life Sciences Inc. has received a notice of exercise of the overallotment option to acquire an additional 2,887,500 common shares at a price of $2.60 per overallotment share, for gross proceeds of $7,507,500 from the syndicate of underwriters led by Canaccord Genuity Corp., and which included RBC Dominion Securities Inc., Beacon Securities Ltd., TD Securities Inc. and Paradigm Capital Inc. The underwriters were granted the overallotment option in connection with the previously announced bought deal offering of common shares of the corporation, which closed on May 6, 2015. Closing of the overallotment option is expected to occur on or about May 28, 2015.
We seek Safe Harbor.
© 2024 Canjex Publishing Ltd. All rights reserved.